H

Healius Ltd
ASX:HLS

Watchlist Manager
Healius Ltd
ASX:HLS
Watchlist
Price: 1.35 AUD 2.66% Market Closed
Market Cap: 980.3m AUD
Have any thoughts about
Healius Ltd?
Write Note

Intrinsic Value

The intrinsic value of one HLS stock under the Base Case scenario is 3.18 AUD. Compared to the current market price of 1.35 AUD, Healius Ltd is Undervalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HLS Intrinsic Value
3.18 AUD
Undervaluation 58%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Healius Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HLS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HLS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Healius Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Healius Ltd

Provide an overview of the primary business activities
of Healius Ltd.

What unique competitive advantages
does Healius Ltd hold over its rivals?

What risks and challenges
does Healius Ltd face in the near future?

Has there been any significant insider trading activity
in Healius Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Healius Ltd.

Provide P/S
for Healius Ltd.

Provide P/E
for Healius Ltd.

Provide P/OCF
for Healius Ltd.

Provide P/FCFE
for Healius Ltd.

Provide P/B
for Healius Ltd.

Provide EV/S
for Healius Ltd.

Provide EV/GP
for Healius Ltd.

Provide EV/EBITDA
for Healius Ltd.

Provide EV/EBIT
for Healius Ltd.

Provide EV/OCF
for Healius Ltd.

Provide EV/FCFF
for Healius Ltd.

Provide EV/IC
for Healius Ltd.

Show me price targets
for Healius Ltd made by professional analysts.

What are the Revenue projections
for Healius Ltd?

How accurate were the past Revenue estimates
for Healius Ltd?

What are the Net Income projections
for Healius Ltd?

How accurate were the past Net Income estimates
for Healius Ltd?

What are the EPS projections
for Healius Ltd?

How accurate were the past EPS estimates
for Healius Ltd?

What are the EBIT projections
for Healius Ltd?

How accurate were the past EBIT estimates
for Healius Ltd?

Compare the revenue forecasts
for Healius Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Healius Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Healius Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Healius Ltd compared to its peers.

Compare the P/E ratios
of Healius Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Healius Ltd with its peers.

Analyze the financial leverage
of Healius Ltd compared to its main competitors.

Show all profitability ratios
for Healius Ltd.

Provide ROE
for Healius Ltd.

Provide ROA
for Healius Ltd.

Provide ROIC
for Healius Ltd.

Provide ROCE
for Healius Ltd.

Provide Gross Margin
for Healius Ltd.

Provide Operating Margin
for Healius Ltd.

Provide Net Margin
for Healius Ltd.

Provide FCF Margin
for Healius Ltd.

Show all solvency ratios
for Healius Ltd.

Provide D/E Ratio
for Healius Ltd.

Provide D/A Ratio
for Healius Ltd.

Provide Interest Coverage Ratio
for Healius Ltd.

Provide Altman Z-Score Ratio
for Healius Ltd.

Provide Quick Ratio
for Healius Ltd.

Provide Current Ratio
for Healius Ltd.

Provide Cash Ratio
for Healius Ltd.

What is the historical Revenue growth
over the last 5 years for Healius Ltd?

What is the historical Net Income growth
over the last 5 years for Healius Ltd?

What is the current Free Cash Flow
of Healius Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Healius Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Healius Ltd

Current Assets 300.1m
Cash & Short-Term Investments 60.1m
Receivables 208.1m
Other Current Assets 31.9m
Non-Current Assets 2.7B
Long-Term Investments 3.2m
PP&E 1.2B
Intangibles 1.4B
Other Non-Current Assets 89.1m
Current Liabilities 600.3m
Accounts Payable 200.9m
Other Current Liabilities 399.4m
Non-Current Liabilities 1.3B
Long-Term Debt 1.3B
Other Non-Current Liabilities 15.2m
Efficiency

Earnings Waterfall
Healius Ltd

Revenue
1.7B AUD
Cost of Revenue
-224.3m AUD
Gross Profit
1.5B AUD
Operating Expenses
-1.5B AUD
Operating Income
65.5m AUD
Other Expenses
-711.3m AUD
Net Income
-645.8m AUD

Free Cash Flow Analysis
Healius Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HLS Profitability Score
Profitability Due Diligence

Healius Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 1-Year Revenue Growth
41/100
Profitability
Score

Healius Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

HLS Solvency Score
Solvency Due Diligence

Healius Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
31/100
Solvency
Score

Healius Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HLS Price Targets Summary
Healius Ltd

Wall Street analysts forecast HLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLS is 1.36 AUD with a low forecast of 1.06 AUD and a high forecast of 1.84 AUD.

Lowest
Price Target
1.06 AUD
21% Downside
Average
Price Target
1.36 AUD
1% Upside
Highest
Price Target
1.84 AUD
36% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HLS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HLS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Healius Ltd

Country

Australia

Industry

Health Care

Market Cap

980.2m AUD

Dividend Yield

0%

Description

Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.

Contact

NEW SOUTH WALES
Sydney
L 6 203 Pacific Hwy, St Leonards
+61294329400.0
www.healius.com.au

IPO

1998-07-03

Employees

11 000

Officers

MD, CEO & Director
Mr. Paul D. Anderson B.Com., C.A.
CFO& Company Secretary
Mr. Stephen Humphries B.Sc.
Head & Group Executive of Healius Pathology
Dr. Jan Van Rooyen
Group Executive of People & Culture
Ms. Paula Bayliss
Advisor
Mr. John McKechnie
Chief Executive of Lumus Imaging
Dr. Phil Lucas
Show More
Chief Operating Officer of Healius Pathology
Ian Mcphan
Head of Group FP&A
Sharon Ng
Group Executive of Operations Transformation
Mr. Arjun Narang
Group Executive of Commercial & Customer
Mr. Jon Eide
Show Less

See Also

Discover More
What is the Intrinsic Value of one HLS stock?

The intrinsic value of one HLS stock under the Base Case scenario is 3.18 AUD.

Is HLS stock undervalued or overvalued?

Compared to the current market price of 1.35 AUD, Healius Ltd is Undervalued by 58%.

Back to Top